ClinicalTrials.Veeva

Menu

Ultrasound-guided Selective Blockade of the Saphenous and Obturator Nerves Following Total Knee Arthroplasty

B

Bispebjerg Hospital

Status and phase

Completed
Phase 4

Conditions

Knee Arthroplasty, Total

Treatments

Drug: nerve block with ropivacaine and with saline
Drug: nerve block with ropivacaine
Drug: nerve block with saline

Study type

Interventional

Funder types

Other

Identifiers

NCT02465827
BispebjergH

Details and patient eligibility

About

The investigators aimed to evaluate the efficacy of selective low volume ultrasound-guided blockades of the saphenous and obturator nerves on dynamic and rest pain 24-hours post-operatively for patients undergoing unilateral primary total knee arthroplasty.

Full description

A femoral nerve block is the recommended strategy in many surgical centers to supplement multimodal analgesic regime following total knee arthroplasty (TKA) (i.e. both for spinal and general anesthesia). However, a femoral nerve block will often result in quadriceps paralysis, and this will increase the risk for the patient to fall as long as the femoral block have effect. Thus, the search for sensory nerve blocks to stop pain after TKA is a very interesting topic. The saphenous nerve is a purely sensory nerve, and the posterior branch of the obturator nerve is a mixed nerve, where the motor component only affects part of the adductor major muscle.

Enrollment

75 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. American Society of Anesthesiologists' physical classification I-III
  2. Age ≥ 18 years undergoing primary unilateral total knee arthroplasty

Exclusion criteria

  1. Inability to cooperate
  2. Inability to speak and understand Danish
  3. Allergy to any drugs used in the study
  4. Drug or alcohol abuse
  5. Pregnancy or nursing
  6. Opioid abusers

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

75 participants in 3 patient groups, including a placebo group

Saphenous and obturator nerve block
Active Comparator group
Description:
5 ml of ropivacaine 0.75% for the saphenous nerve and 10 ml of ropivacaine 0,75% for the obturator nerve block. Ropivacaine 0.75% for nerve blockades for both nerves mentioned.
Treatment:
Drug: nerve block with ropivacaine
Saphenous nerve block
Active Comparator group
Description:
5 ml of ropivacaine 0.75% for the saphenous nerve and 10 ml of isotonic saline for the obturator nerve block. Ropivacaine 0.75% for the saphenous nerve block and saline for the obturator nerve block
Treatment:
Drug: nerve block with ropivacaine and with saline
Placebo nerve block
Placebo Comparator group
Description:
5 ml of isotonic saline for the saphenous nerve and 10 ml of isotonic saline for the obturator nerve block. Saline for nerve blockades for both nerves mentioned.
Treatment:
Drug: nerve block with saline

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems